The Boston-based company aims to accelerate the drug discovery process for cancer therapies that are both more effective and less toxic.
Category: alexknappblog
Forbes Favorites 2020: The Year’s Best Non-Pandemic Healthcare Stories
Although Covid-19 dominated the discussion, there was a lot more happening in the healthcare industry in 2020. Here are six of the best stories of the year.
Forbes Favorites 2020: The Year’s Best Covid-19 Healthcare Stories
From the frontlines of the pandemic to the companies producing the first vaccines, here are seven of the best stories about the fight against Covid-19.
FDA Review Of Pfizer Vaccine Data Confirms Protection Against Covid-19 Infection
The positive data will inform the regulatory body’s discussion over whether to authorize use of the vaccine, which could happen as early as Thursday.
Here’s What You Need To Know About AstraZeneca’s Covid-19 Vaccine
AstraZeneca, with partner Oxford University, released preliminary data for its phase 3 Covid-19 Monday showing that the vaccine may be up to 90% effective.
What You Need To Know About Moderna’s Covid-19 Vaccine
The Boston-based biotech firm is neck and neck with Pfizer in the race to have the first Covid-19 vaccine authorized for use.
What You Need To Know About Pfizer’s Covid-19 Vaccine
Developed with Pfizer’s partner BioNTech, if all goes well this vaccine would be the first of its kind to receive FDA approval.
How The Biden Presidency Plans To Combat Covid-19
Free testing, mask mandates, vaccine distribution and clear public guidance form the cornerstones of the President-elect’s pandemic response.
Meet The Married Couple Who Just Raised $10 Million To Improve Cancer Treatments For Dogs
Ben Lewis and Christina Lopes just finalized a series A for their company, One Health, which is working to improve medical treatments for dogs — in ways that could improve cancer care in humans as well.
Lilly’s Rheumatoid Arthritis Drug, Combined With Remdesivir, Benefits Covid-19 Patients Who Need Oxygen
Lilly announced additional findings indicating that its rheumatoid arthritis drug, baricitinib, may improve the health of severe Covid-19 patients when used in combination with Gilead Science’s antiviral drug remdesivir.
